OrbiMed’s Prelude Therapeutics PRLD Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$8.83M	Hold	10,909,256	–	–	0.22%	62
2025 Q1	$8.38M	Hold	10,909,256	–	–	0.2%	66
2024 Q4	$13.9M	Hold	10,909,256	–	–	0.29%	62
2024 Q3	$22.6M	Hold	10,909,256	–	–	0.41%	62
2024 Q2	$41.6M	Hold	10,909,256	–	–	0.82%	38
2024 Q1	$51.7M	Hold	10,909,256	–	–	0.95%	37
2023 Q4	$46.6M	Hold	10,909,256	–	–	0.93%	40
2023 Q3	$33.7M	Hold	10,909,256	–	–	0.72%	52
2023 Q2	$49.1M	Buy	10,909,256 +869,565	+9%	+$3.91M	0.89%	41
2023 Q1	$57.2M	Hold	10,039,691	–	–	1.12%	28
2022 Q4	$60.6M	Hold	10,039,691	–	–	1.16%	31
2022 Q3	$66.4K	Hold	10,039,691	–	–	1.23%	27
2022 Q2	$52.4K	Hold	10,039,691	–	–	0.95%	35
2022 Q1	$69.3M	Hold	10,039,691	–	–	1.12%	32
2021 Q4	$125M	Hold	10,039,691	–	–	1.61%	21
2021 Q3	$314M	Hold	10,039,691	–	–	3.45%	2
2021 Q2	$287M	Hold	10,039,691	–	–	2.91%	6
2021 Q1	$435M	Sell	10,039,691 -5,555,186	-36%	-$241M	4.07%	3
2020 Q4	$1.12B	Hold	15,594,877	–	–	9.76%	1
2020 Q3	$470M	Buy	+15,594,877	New	+$470M	5.91%	1